Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysis

Mitchell F. Brin(AbbVie (United States)), Elisabeth Lee(Allergan (Ireland)), Makoto Kawashima(Tokyo Women's Medical University), Steven Liew(St Vincent's Clinic), Terry Boodhoo(AbbVie (United States)), Jean Carruthers(University of British Columbia), Yan Wu(Guangzhou University of Chinese Medicine), Koen De Boulle(Onze Lieve Vrouwziekenhuis Hospital), Irina Yushmanova(AbbVie (United States)), Alastair Carruthers(University of British Columbia), Alexander Rivkin
JAAD International
September 9, 2023
10.1016/j.jdin.2023.07.021
Cited by 7

Related Papers

The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
|Nature Genetics|1997|1k
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
|The Lancet|2015|569
The P300 and reward valence, magnitude, and expectancy in outcome evaluation
|Brain Research|2009|474
Global Aesthetics Consensus: Avoidance and Management of Complications from Hyaluronic Acid Fillers—Evidence- and Opinion-Based Review and Consensus Recommendations
|Plastic & Reconstructive Surgery|2016|326
Updating the diagnosis, classification and assessment of rosacea: recommendations from the global <scp>ROS</scp> acea <scp>CO</scp> nsensus ( <scp>ROSCO</scp> ) panel
|British Journal of Dermatology|2016|287